TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/13/2024
Back to search
Official data from USPTO
CANCERVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/13/2024
Trademark type
Combined
Nice classes
42
Filing date
02/02/2023
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
06/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
09/27/2022
First use in commerce
09/27/2022
Drawing code
5
Owner type
03
Owner location
Santa Barbara, CA
Examiner
PARKS, KIMBERLY
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized text CANCERVAX.
Holders and representatives
Holders
CancerVAX, Inc.
Representatives
Jeffery M. Lillywhite KIMBALL ANDERSON
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical drug development services; Pharmaceutical research services; Providing information about medical research in the field of cancerpharmaceutical drugscancer risksImmunotherapy
Publications
History of USPTO decisions and trademark events.
15 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/13/2024
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/02/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/13/2023
GNRT
NON-FINAL ACTION E-MAILED
11/13/2023
CNRT
NON-FINAL ACTION WRITTEN
11/13/2023
DOCK
ASSIGNED TO EXAMINER
10/31/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/21/2023
NWAP
NEW APPLICATION ENTERED
02/07/2023
Continuous trademark protection
Get notified about every new filing that threatens CANCERVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.